secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sarepta Therapeutics, Inc. (SRPT)
CIK:        0000873303
Form:       8-K
Filed at:   2024-09-16T23:59:59+00:00
Accession:  0000950170-24-106619
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sarepta appoints Deirdre Connelly to board, increases board size to 9
---------------------------------------------------------------------

- Deirdre Connelly appointed as Class I director effective Sept. 12, 2024, term through 2026 annual meeting.
- Initial equity grant of $712,500 in value, split equally between RSUs and stock options.
- Equity vests in three equal annual installments starting Sept. 12, 2025; annual cash retainer $60,000.
- Board amended bylaws to increase maximum director limit from 8 to 9, effective immediately.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/873303/000095017024106619/0000950170-24-106619-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/873303/000095017024106619/srpt-20240912.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-106619

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer